Youwei Bi
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Lung Cancer Treatments and Mutations
- Advanced Breast Cancer Therapies
Papers in
-
- Lung Cancer Treatments and Mutations 4
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Oncology 7
- HER2/EGFR in Cancer Research 3
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Yaning Wang (6 shared papers)Richard Pazdur (8 shared papers)Banu A. Karimi-Shah (2 shared papers)Dinko Rekić (2 shared papers)Badrul A. Chowdhury (2 shared papers)Julia A. Beaver (4 shared papers)Harpreet Singh (4 shared papers)Atiqur Rahman (2 shared papers)
- Journals
- Clinical Cancer Research (6 papers)The Journal of Clinical Pharmacology (5 papers)Clinical Pharmacology & Therapeutics (3 papers)The AAPS Journal (3 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomIraq
In The Last Decade
Youwei Bi
22 papers receiving 757 citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 275
- Pulmonary and Respiratory Medicine 307
- Cancer Research 89
- Genetics 55
- Pharmacology 41
Countries citing papers authored by Youwei Bi
This map shows the geographic impact of Youwei Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youwei Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youwei Bi more than expected).
Fields of papers citing papers by Youwei Bi
This network shows the impact of papers produced by Youwei Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youwei Bi. The network helps show where Youwei Bi may publish in the future.
Co-authors
The 25 scholars most cited alongside Youwei Bi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | FDA Approval Summary: Sotorasib for KRAS G12C -Mutated Metastatic NSCLC Hit paper breakdown → | 2021 | 193 |
| 2 | 2017 | 124 | |
| 3 | 2018 | 88 | |
| 4 | 2015 | 43 | |
| 5 | 2019 | 42 | |
| 6 | 2019 | 39 | |
| 7 | 2022 | 36 | |
| 8 | 2019 | 34 | |
| 9 | 2023 | 33 | |
| 10 | 2023 | 23 | |
| 11 | 2023 | 21 | |
| 12 | 2022 | 19 | |
| 13 | 2021 | 17 | |
| 14 | 2018 | 15 | |
| 15 | 2023 | 11 | |
| 16 | 2021 | 9 | |
| 17 | 2018 | 7 | |
| 18 | 2020 | 5 | |
| 19 | 2024 | 3 | |
| 20 | 2024 | 3 |
About Youwei Bi
Youwei Bi is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Pediatrics, Perinatology and Child Health, Pharmacology and Surgery, having authored 25 papers that have together received 768 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Pharmaceutical studies and practices (6 papers), Lung Cancer Treatments and Mutations (4 papers), HER2/EGFR in Cancer Research (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Autoimmune and Inflammatory Disorders Research (2 papers) and Statistical Methods in Clinical Trials (2 papers). The work is most often cited by research in Oncology (275 citations), Pulmonary and Respiratory Medicine (307 citations), Cancer Research (89 citations), Genetics (55 citations) and Pharmacology (41 citations). Youwei Bi has collaborated with scholars based in United States, United Kingdom and Iraq. Frequent co-authors include Yaning Wang, Richard Pazdur, Banu A. Karimi-Shah, Dinko Rekić, Badrul A. Chowdhury, Julia A. Beaver, Harpreet Singh, Atiqur Rahman, Pallavi S. Mishra‐Kalyani and Nicole Drezner. Their work appears in journals such as Clinical Cancer Research, The Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, The AAPS Journal and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.